Back to Search
Start Over
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
- Source :
- European Journal of Nuclear Medicine and Molecular Imaging. 49:1012-1020
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
-
Abstract
- To determine the prognostic value of sarcopenia measurements done on staging 2-[18F] FDG PET/CT together with metabolic activity of the tumor in patients with adenocarcinoma esophagogastric cancer with surgical treatment. Patients with early-stage, surgically treated esophageal adenocarcinoma and available pre-treatment 2-[18F] FDG PET/CT were included. The standard uptake value (SUV) and SUV normalized by lean body mass (SUL) were recorded. Skeletal muscle index (SMI) was measured at the L3 level on the CT component of the PET/CT. Sarcopenia was defined as SMI
- Subjects :
- medicine.medical_specialty
PET-CT
business.industry
Proportional hazards model
Lymphovascular invasion
Standardized uptake value
General Medicine
Esophageal cancer
medicine.disease
Gastroenterology
Sarcopenia
Internal medicine
medicine
Adenocarcinoma
Radiology, Nuclear Medicine and imaging
Stage (cooking)
business
Subjects
Details
- ISSN :
- 16197089 and 16197070
- Volume :
- 49
- Database :
- OpenAIRE
- Journal :
- European Journal of Nuclear Medicine and Molecular Imaging
- Accession number :
- edsair.doi...........6fc1e50dac6e98ae07e1f0718df25e2d